EUVIMEDAtrasti EUVIMED
Crossref

Dysregulation of bone and myocardial inorganic phosphate transporters and downstream cell signals in early-stage mild chronic kidney disease-mineral and bone disorder: An experimental study

Evdokia Bogdanova, Airat Sadykov, Galina Ivanova, Olga Beresneva, Alexandr Zhuravlev, Natalia Semenova, Vladimir Sharoyko, Anton Kutikhin, Vladimir Dobronravov

Bone · 2025

DOI: 10.1016/j.bone.2025.117653 ↗

At a glance

Journal article in Bone, 2025. Written by Evdokia Bogdanova and 8 co-authors. Institution: Research Institute of Nephrology Pavlov University, 197022, Saint Petersburg, Russia. Electronic address: evdokia.bogdanova@gmail.com. Major MEDLINE topics: Myocardium, Bone and Bones, Chronic Kidney Disease-Mineral and Bone Disorder, Signal Transduction. 74 references. Funded by: Russian Academy of Sciences, Federal Agency for Scientific Organizations.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Chronic kidney disease-mineral and bone disorder (CKD-MBD) significantly contributes to cardiovascular morbidity and mortality in CKD patients, raising questions about the molecular mechanisms linking cardiac and bone abnormalities. In this study, adult male spontaneously hypertensive rats (SHRs) underwent 3/4 nephrectomy (Nx) to induce mild CKD-MBD, with sham-operated SHRs (SO) serving as controls. All animals were fed a standard diet containing 0.6 % phosphorus. Exhibiting renal dysfunction comparable to human CKD stage 2, Nx rats had higher levels of serum inorganic phosphate (Pi), calciprotein particles (CPPs), and myocardial phosphorus (P) without differences in serum PTH, FGF23, kidney and bone P content. Compared to controls, the experimental group showed features of lower bone turnover with reduced osteoblast and osteocyte numbers and decreased eroded perimeter, alongside myocardial hypertrophy and fibrosis. In bone and myocardium, reciprocal alterations of a tissue expression of Pi-transporters and MAPK-signals were found. Reduced bone turnover associated with a lower tissue expression of Slc20a1 (PiT1) and osteogenic Mapk1 (ERK2). In myocardium, Slc20a2 (PiT2) and phospho-ERK1/2 expression were upregulated at gene and protein levels in Nx rats versus controls. These findings suggest that, in the setting of CKD-associated Pi retention, maladaptive bone and myocardial responses are mediated by the dysregulation of Pi transporters and down-stream ERK1/2 signals.

Subjects

MeSH terms (MEDLINE)

MyocardiumBone and BonesChronic Kidney Disease-Mineral and Bone DisorderSignal TransductionPhosphate Transport ProteinsAnimalsMaleFibroblast Growth Factor-23Rats, Inbred SHRRatsPhosphatesSodium-Phosphate Cotransporter Proteins, Type IIIFibroblast Growth Factors

Author keywords

Chronic kidney disease–mineral and bone disorder (CKD-MBD)ERK1/2 MAPK pathwayInorganic phosphateMyocardial fibrosisPiT1 (Slc20a1)PiT2 (Slc20a2)Static bone histomorphometry

Substances

Fibroblast Growth Factor-23Fgf23 protein, ratPhosphatesPhosphate Transport ProteinsSodium-Phosphate Cotransporter Proteins, Type IIIFibroblast Growth Factors

Authors and institutions

  • Research Institute of Nephrology Pavlov University, 197022, Saint Petersburg, Russia. Electronic address: evdokia.bogdanova@gmail.com.
  • Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, Pavlov University, 197022, Saint Petersburg, Russia. Electronic address: bmt-director@1spbgmu.ru.
  • Laboratory of Cardiovascular and Lymphatic Systems, Pavlov Institute of Physiology, 199034, Saint Petersburg, Russia. Electronic address: ivanovagt@infran.ru.
  • Research Institute of Nephrology Pavlov University, 197022, Saint Petersburg, Russia. Electronic address: beresnevaolga@list.ru.
  • Department of Molecular Genetic and Nanobiological Technologies, Pavlov University, 197022, Saint Petersburg, Russia.
  • Research Department of Pathomorphology Almazov National Medical Research Center, 197022, Saint Petersburg, Russia.

Funding

  • Russian Academy of Sciences
  • Federal Agency for Scientific Organizations

Cite

APA

Bogdanova, E., Sadykov, A., Ivanova, G., Beresneva, O., Zhuravlev, A., Semenova, N., Sharoyko, V., Kutikhin, A., & Dobronravov, V. (2025). Dysregulation of bone and myocardial inorganic phosphate transporters and downstream cell signals in early-stage mild chronic kidney disease-mineral and bone disorder: An experimental study. Bone. https://doi.org/10.1016/j.bone.2025.117653

Vancouver

Bogdanova E, Sadykov A, Ivanova G, Beresneva O, Zhuravlev A, Semenova N, et al. Dysregulation of bone and myocardial inorganic phosphate transporters and downstream cell signals in early-stage mild chronic kidney disease-mineral and bone disorder: An experimental study. Bone. 2025. doi:10.1016/j.bone.2025.117653

BibTeX
@article{Bogdanova2025,
  author = {Bogdanova, Evdokia and Sadykov, Airat and Ivanova, Galina and Beresneva, Olga and Zhuravlev, Alexandr and Semenova, Natalia and Sharoyko, Vladimir and Kutikhin, Anton and Dobronravov, Vladimir},
  title = {Dysregulation of bone and myocardial inorganic phosphate transporters and downstream cell signals in early-stage mild chronic kidney disease-mineral and bone disorder: An experimental study},
  journal = {Bone},
  year = {2025},
  doi = {10.1016/j.bone.2025.117653}
}
Start for free →